Nafazolina Pensa (Naphazoline Nitrate)

Naphazoline Nitrate, the active ingredient in Nafazolina Pensa, is a alpha‑adrenergic agonist presented as a nasal spray for intranasal use. It relieves nasal congestion associated with rhinitis, the common cold and other upper‑respiratory conditions.

GNH USA supplies Nafazolina Pensa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naphazoline Nitrate acts on the nasal vasculature to reduce swelling and improve airflow. - Nasal congestion: provides rapid reduction of mucosal edema and eases breathing. - Allergic rhinitis: alleviates blockage caused by allergic inflammation. - Common cold: relieves nasal stuffiness and improves comfort during viral upper‑respiratory infections.

Naphazoline Nitrate may cause local and systemic reactions.

Common Side Effects: - Nasal irritation or burning sensation - Dryness of the nasal mucosa - Sneezing - Mild headache - Transient epistaxis (nosebleed) - Taste disturbance

Serious or Rare Side Effects: - Rebound nasal congestion (rhinitis medicamentosa) with prolonged use - Elevated blood pressure or hypertension - Tachycardia or cardiac arrhythmias - Severe allergic reaction (anaphylaxis) - Ocular ischemia or visual disturbances - Central nervous system effects such as dizziness or confusion

Before using Nafazolina Pensa, consider the following safety measures. - Age restriction: avoid use in children under 12 years unless directed by a clinician. - Duration limit: do not exceed three consecutive days of use to prevent rebound congestion. - Cardiovascular conditions: avoid if you have uncontrolled hypertension, coronary artery disease, or severe heart failure. - Ocular disorders: contraindicated in patients with narrow-angle glaucoma or recent eye surgery. - Pregnancy and lactation: safety not established; consult a healthcare professional before use. - Store at room temperature below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Naphazoline Nitrate can interact with other medications that affect vascular tone or sympathetic activity.

Major Interactions (Avoid): - Other intranasal decongestants (e.g., oxymetazoline, phenylephrine) – risk of excessive vasoconstriction. - Monoamine oxidase inhibitors (MAOIs) – potential for hypertensive crisis. - Tricyclic antidepressants – additive cardiovascular stimulation.

Moderate Interactions (Monitor Closely):\n- Antihypertensive agents – may reduce their effectiveness. - Beta‑blockers – possible additive increase in blood pressure. - Sympathomimetic drugs (e.g., ephedrine) – enhanced systemic adrenergic effects.